DEL and Display Technologies Empower Discovery of Peptide Drugs
In recent years, peptide-based therapeutics have emerged as a significant class of drugs in the pharmaceutical landscape, offering numerous advantages,...
Continue Reading
In recent years, peptide-based therapeutics have emerged as a significant class of drugs in the pharmaceutical landscape, offering numerous advantages,...
Continue Reading
High-throughput screening (HTS) remains a foundational technology in early drug discovery, responsible for identifying approximately one-third of today’s clinical candidates....
Continue Reading
Introduction: In the realm of modern therapeutics, peptides have emerged as a powerful and versatile class of molecules, unlocking their...
Continue Reading
WuXi AppTec offers a comprehensive platform of in silico drug discovery services to accelerate the process of hit finding and...
Continue Reading
Molecular glues possess the remarkable ability to induce protein-protein interactions. In the pursuit of targeting the CDK12/CCNK/DDB1 complex, an ASMS...
Continue Reading
Drug Discovery Chemistry Conference 2023 Powerful biophysical and structural biology tools enable the study of large numbers of covalent fragments...
Continue Reading
https://www.nature.com/articles/s43586-021-00084-5 Abstract DNA-encoded chemical library (DECL) technology is used by the pharmaceutical industry to discover small molecules capable of modulating...
Continue Reading
Fragment-based drug discovery (FBDD) is a method used for finding hit compounds as one strategy of hit identification in the...
Continue Reading
WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to...
Continue Reading